1-20 of 23
Germana Beltrami
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Centralized MRD Assessment in Gimema AML1718 Trial, a Phase 2 Open-Label Study of Venetoclax Combined with Intensified FLAI Chemotherapy (V-FLAI) As Induction Therapy of Non Low-Risk AML

Paola Minetto, Fabio Guolo, Sara Rosellini, Alfonso Piciocchi, Giovanni Marconi, Ernesta Audisio, Giorgio Priolo, Cristina Papayannidis, Maurizio Martelli, Giovanni Marsili, Monica Bocchia, Francesco Lanza, Albana Lico, Fabio Ciceri, Matteo Giovanni Della Porta, Marco Frigeni, Luisa Giaccone, Germana Beltrami, Erika Borlenghi, Maria Chiara Di Chio, Carmine Selleri, Enrico Crea, Irene Urbino, Chiara Sartor, Clara Minotti, Valentina Arena, Jacopo Nanni, Giorgia Simonetti, Maria Teresa Bochicchio, Giuseppe Saglio, Adriano Venditti, Marco Vignetti, Paola Fazi, Elisabetta Tedone, Giovanni Martinelli, Roberto Massimo Lemoli
Journal: Blood
Blood (2024) 144 (Supplement 1): 1574.
https://doi.org/10.1182/blood-2024-198139
Published: 2024
Journal Articles

Survival Analysis of Gimema AML1718, a Safety Run-in and Phase 2 Open-Label Study of Venetoclax, Fludarabine, Idarubicin and Cytarabine (V-FLAI) in the Induction Therapy of Non Low-Risk Acute Myeloid Leukemia

Giovanni Marconi, Alfonso Piciocchi, Ernesta Audisio, Cristina Papayannidis, Fabio Guolo, Marco Cerrano, Valentina Arena, Saveria Capria, Michela Rondoni, Matteo Giovanni Della Porta, Germana Beltrami, Monica Bocchia, Albana Lico, Luisa Giaccone, Marianna Rossi, Catello Califano, Matteo Giovanni Carrabba, Chiara Cattaneo, Marco Frigeni, Maria Chiara Di Chio, Bianca Serio, Roberto Freilone, Antonio Curti, Paola Minetto, Giovanni Marsili, Clara Minotti, Beatrice Anna Zannetti, Francesca Cotugno, Jacopo Nanni, Giorgia Simonetti, Maria Teresa Bochicchio, Sara Rosellini, Elisabetta Tedone, Adriano Venditti, Roberto Massimo Lemoli, Marco Vignetti, Paola Fazi, Giovanni Martinelli
Journal: Blood
Blood (2024) 144 (Supplement 1): 2891.
https://doi.org/10.1182/blood-2024-207842
Published: 2024
Journal Articles

Assessment of Transitioning from High-Potency to Low-Potency Inhibitors in Chronic Myeloid Leukemia (CML) Patients: The Downgrading-Impact Project, a CML Campus Study

Elisabetta Abruzzese, Simona Bernardi, Uros Markovic, Malgorzata Monika Trawinska, Sara Barulli, Alessandro Maggi, Sara Galimberti, Cristina Bucelli, Daniele Sannipoli, Mariella D'Adda, Elena Chiara, Massimiliano Bonifacio, Antonella Russo Rossi, Germana Beltrami, Sabina Russo, Elena Crisa', Grazia Sanpaolo, Francesco Cavazzini, Giuseppina Loglisci, Carmen Fava, Federica Maria Catania, Anna Rita Scortechini, Barbara Scappini, Giovanna Rege Cambrin, Gianni Binotto, Monica Bocchia, Davide Facchinelli, Ambra Di Veroli, Sara Pasquina Pascale, Annapaola Leporace, Matia Bernardi, Monica Crugnola
Journal: Blood
Blood (2024) 144 (Supplement 1): 4532.
https://doi.org/10.1182/blood-2024-211476
Published: 2024
Journal Articles

Treatment-Free Remission in CML Patients Discontinuing Post-First Line Therapy

Selene Grano, Valentina Bonuomo, Emanuele Koumantakis, Paola Berchialla, Fausto Castagnetti, Massimo Martino, Chiara Elena, Monica Bocchia, Isabella Capodanno, Tamara Intermesoli, Maria Cristina Miggiano, Carlo Gambacorti-Passerini, Alessandra Iurlo, Francesca Lunghi, Luigiana Luciano, Elisabetta Abruzzese, Angelo Michele Carella, Massimo Breccia, Felicetto Ferrara, Sabrina Leonetti Crescenzi, Barbara Scappini, Marco De Gobbi, Federica Sorà, Davide Rapezzi, Debora Luzi, Sara Galimberti, Monica Crugnola, Anna Rita Scortechini, Alessandro Maggi, Massimiliano Bonifacio, Mario Annunziata, Giovanni Caocci, Germana Beltrami, Francesco Cavazzini, Giuseppe Pietrantuono, Leonardo Campiotti, Fabio Stagno, Caterina Musolino, Carmen Fava
Journal: Blood
Blood (2024) 144 (Supplement 1): 1778.
https://doi.org/10.1182/blood-2024-200208
Published: 2024
Journal Articles

Tyrosine Kinase Inhibitors Discontinuation in Chronic Myeloid Leukemia: Observational Study of 673 Patients in Italy

Valentina Bonuomo, Emanuele Koumantakis, Selene Grano, Paola Berchialla, Fausto Castagnetti, Bruno Martino, Chiara Elena, Monica Bocchia, Isabella Capodanno, Tamara Intermesoli, Maria Cristina Miggiano, Carlo Gambacorti-Passerini, Alessandra Iurlo, Francesca Lunghi, Luigiana Luciano, Elisabetta Abruzzese, Angelo Michele Carella, Massimo Breccia, Felicetto Ferrara, Sabrina Leonetti Crescenzi, Barbara Scappini, Marco De Gobbi, Federica Sorà, Davide Rapezzi, Debora Luzi, Sara Galimberti, Monica Crugnola, Anna Rita Scortechini, Alessandro Maggi, Massimiliano Bonifacio, Mario Annunziata, Giovanni Caocci, Germana Beltrami, Francesco Cavazzini, Giuseppe Pietrantuono, Leonardo Campiotti, Fabio Stagno, Caterina Musolino, Daniela Cilloni, Giuseppe Saglio, Carmen Fava
Journal: Blood
Blood (2024) 144 (Supplement 1): 3162.
https://doi.org/10.1182/blood-2024-201493
Published: 2024
Journal Articles

On the Children Side. Overview of 194 Outcomes from Gimema Registry of Conception/Pregnancy in Chronic Myeloid Leukemia (CML)

Elisabetta Abruzzese, Elena Chiara, Fausto Castagnetti, Mario Annunziata, Carlo Gambacorti-Passerini, Luigiana Luciano, Antonella Russo Rossi, Alessandra Iurlo, Isabella Capodanno, Valentina Giai, Mariella D'Adda, Fabio Stagno, Antonella Gozzini, Mario Tiribelli, Federica Sorà, Sara Galimberti, Monica Bocchia, Germana Beltrami, Carmen Fava, Maria Cristina Miggiano, Massimo Breccia, Marco Cerrano, Anna Rita Scortechini, Olga Mulas, Clementina Caracciolo, Stefana Impera, Claudio Fozza, Alessandra Malato, Lucia Mastrullo, Marzia Salvucci, Monia Lunghi, Filippo Gherlinzoni, Paolo De Fabritiis, Paola Fazi, Sonia Maria Orlando, Alfonso Piciocchi, Fabrizio Pane
Journal: Blood
Blood (2023) 142 (Supplement 1): 3178.
https://doi.org/10.1182/blood-2023-188305
Published: 2023
Journal Articles

Centralized MRD Assessment at Early Timepoints in Gimema AML1718 Trial, a Phase 2 Open-Label Study of Venetoclax, Fludarabine, Idarubicin and Cytarabine (V-FLAI) in the Induction Therapy of Non Low-Risk AML

Paola Minetto, Fabio Guolo, Sara Rosellini, Alfonso Piciocchi, Giovanni Marconi, Ernesta Audisio, Giorgio Priolo, Cristina Papayannidis, Maurizio Martelli, Francesca Paola Paoloni, Monica Bocchia, Francesco Lanza, Albana Lico, Fabio Ciceri, Matteo Giovanni Della Porta, Marco Frigeni, Luisa Giaccone, Germana Beltrami, Erika Borlenghi, Maria Chiara Di Chio, Carmine Selleri, Enrico Crea, Irene Urbino, Chiara Sartor, Clara Minotti, Valentina Arena, Jacopo Nanni, Giorgia Simonetti, Maria Teresa Bochicchio, Giuseppe Saglio, Adriano Venditti, Marco Vignetti, Paola Fazi, Elisabetta Tedone, Giovanni Martinelli, Roberto M. Lemoli
Journal: Blood
Blood (2023) 142 (Supplement 1): 1567.
https://doi.org/10.1182/blood-2023-189777
Published: 2023
Journal Articles

Phase II Study on Venetoclax (Ven) Plus Decitabine (Dec) (Ven-Dec) for Elderly (≥60 <75years) Patients with Newly Diagnosed High-Intermediate Risk Acute Myeloid Leukemia (AML) Elegible for Allogeneic Stem Cell Transplantation: Final Report of Ven DEC GITMO Study

Domenico Russo, Nicola Polverelli, Stella Santarone, Francesco Onida, Luca Castagna, Stefania Bramanti, A. M. Carella, Roberto Sorasio, Attilio Olivieri, Germana Beltrami, Antonio Curti, Calogero Vetro, Valentina Mancini, Elisabetta Terruzzi, Massimo Bernardi, Piero Galieni, Pellegrino Musto, Raffaella Cerretti, Luisa Giaccone, Cristina Skert, Erika Borlenghi, Mirko Farina, Alessandro Leoni, Vera Radici, Simona Bernardi, Marika Vezzoli, Stefano Calza, Angela Gheorghiu, Michele Malagola, Massimo Martino, Fabio Ciceri
Journal: Blood
Blood (2023) 142 (Supplement 1): 1513.
https://doi.org/10.1182/blood-2023-185045
Published: 2023
Journal Articles

Tagraxofusp Administered Concomitantly with Intrathecal Chemotherapy in Patients with BPDCN who Either Have or are Considered High-risk to Develop CNS Disease is a Safe and Effective Treatment Strategy: An Italian Multicenter Experience

Giulia Rivoli, Germana Beltrami, Anna M. Raiola, Carole Paley, Marcello Riggi, Alida Dominietto, Emanuele Angelucci
Journal: Blood
Blood (2022) 140 (Supplement 1): 13271–13272.
https://doi.org/10.1182/blood-2022-158985
Published: 2022
Journal Articles

Gimema AML1718 Part 1: Planned Interim Analysis of a Safety Run-in and Phase 2 Open-Label Study of Venetoclax, Fludarabine, Idarubicin and Cytarabine (V-FLAI) in the Induction Therapy of Non Low-Risk Acute Myeloid Leukemia

Giovanni Marconi, Alfonso Piciocchi, Ernesta Audisio, Giorgio Priolo, Cristina Papayannidis, Maurizio Martelli, Francesca Paoloni, Roberto Massimo Lemoli, Monica Bocchia, Francesco Lanza, Albana Lico, Fabio Ciceri, Matteo G. Della Porta, Marco Frigeni, Luisa Giaccone, Germana Beltrami, Erika Borlenghi, Maria Chiara Di Chio, Carmine Selleri, Enrico Crea, Irene Urbino, Chiara Sartor, Clara Minotti, Fabio Guolo, Edoardo La Sala, Jacopo Nanni, Giorgia Simonetti, Maria Teresa Bochicchio, Giuseppe Saglio, Adriano Venditti, Marco Vignetti, Paola Fazi, Giovanni Martinelli
Journal: Blood
Blood (2022) 140 (Supplement 1): 1705–1707.
https://doi.org/10.1182/blood-2022-157393
Published: 2022
Journal Articles

The QUAZAR AML-001 Maintenance Trial: Results of a Phase III International, Randomized, Double-Blind, Placebo-Controlled Study of CC-486 (Oral Formulation of Azacitidine) in Patients with Acute Myeloid Leukemia (AML) in First Remission

Andrew H. Wei, MBBS, FRACP, FRCPA, PhD, Hartmut Döhner, MD, Christopher Pocock, MBBS, Pau Montesinos, MD PhD, Boris Afanasyev, MD DSci, Hervé Dombret, MD, Farhad Ravandi, MD, Hamid Sayar, MD MSc, Jun Ho Jang, MD PhD, Kimmo Porkka, MD, Dominik Selleslag, MD, Irwindeep Sandhu, MD, Mehmet Turgut, MD, Valentina Giai, MD, Yishai Ofran, MD, Merih Kizil Cakar, MD, Aida Botelho de Sousa, MD, Justyna Rybka, MD PhD, Chiara Frairia, MD, Lorenza Borin, MD, Germana Beltrami, MD, Jaroslav Cermak, MD PhD, Gert J. Ossenkoppele, MD PhD, Ignazia La Torre, MD, Barry Skikne, MD, Keshava Kumar, PhD, Qian Dong, DrPH, CL Beach, PharmD, Gail J. Roboz, MD
Journal: Blood
Blood (2019) 134 (Supplement_2): LBA-3.
https://doi.org/10.1182/blood-2019-132405
Published: 2019
Journal Articles

Haploidentical Allogeneic Hemopoietic Stem Cell Transplant for High Risk Myelodysplastic Syndrome

Anna Maria Raiola, MD, Sara Aquino, MD, Germana Beltrami, MD, Stefania Bregante, MD, Fabio Cruciani, MD, Carmen Di Grazia, MD, Alida Dominietto, MD, Anna Ghiso, MD, Francesca Gualandi, MD, Adalberto Ibatici, MD, Teresa Lamparelli, MD, Carlo Marani, MD, Maria Teresa van Lint, MD, Riccardo Varaldo, MD, Andrea Bacigalupo, MD, Emanuele Angelucci, MD
Journal: Blood
Blood (2016) 128 (22): 3173.
https://doi.org/10.1182/blood.V128.22.3173.3173
Published: 2016
Journal Articles

The Prognostic Relevance of Comprehensive Risk Score Is Modulated By Therapy: Analysis of 292 Acute Myeloid Leukemia Patients Registered at the Genova Acute Leukemia Registry (REGAL)

Fabio Guolo, MD, Paola Minetto, MD, Elena Clavio, Giordana Pastori, MD, Daniela Guardo, MD, Lisette Del Corso, MD, Chiara Ghiggi, PhD, Maurizio Miglino, PhD, Germana Beltrami, MD, Angelo Michele Carella, Roberto Massimo Lemoli, MD, Andrea Bacigalupo, MD, Marco Gobbi, MD, Marino Clavio, MD
Journal: Blood
Blood (2015) 126 (23): 4885.
https://doi.org/10.1182/blood.V126.23.4885.4885
Published: 2015
Journal Articles

The Impact of Comorbidities on Clinical Outcome of Patients with Myelodysplastic Syndromes: A Real-Life Survey

Enrico Balleari, MD, Chiara Salvetti, MD, Andrea Bacigalupo, MD, Gianluca Forni, MD, Marco Gobbi, MD, Riccardo Ghio, PhD MD, Marco Scudeletti, MD, Rodolfo Tassara, MD, Giovanni Berisso, MD, Tullio Calzamiglia, MD, Eleonora Arboscello, MD, Germana Beltrami, MD, Micaela Bergamaschi, MD, Maurizio Cavalleri, MD, Lisette Del Corso, MD, Serena Favorini, MD, Rosa Filiberti, BS, Riccardo Goretti, MD, Maurizio Miglino, PhD, Laura Mitschoning, MD, Elisa Molinari, MD, Omar Racchi, MD, Marino Clavio, MD
Journal: Blood
Blood (2014) 124 (21): 4668.
https://doi.org/10.1182/blood.V124.21.4668.4668
Published: 2014
Journal Articles

Interferon-Alpha (IFN-a) Is Able To Maintain Complete Molecular Response (CMR) In Chronic Myeloid Leukemia (CML) Patients Who Maintain Undetectable disease After Imatinib (IM) Discontinuation

Angelo Michele Carella, MD, Germana Beltrami, MD, Chiara Ghiggi, MD
Journal: Blood
Blood (2013) 122 (21): 5195.
https://doi.org/10.1182/blood.V122.21.5195.5195
Published: 2013
Journal Articles

Finding of Kinase Domain Mutations at Diagnosis IN PATIENTS with Chronic PHASE Chronic Myeloid Leukemia (CP-CML) MAY Identify Those at High RISK of Disease Progression.

Angelo Michele Carella, Gabriella Cirmena, Gioacchino Catania, Gianmatteo Pica, Germana Beltrami, Alberto Ballestrero, Franco Patrone, Anna Garuti
Journal: Blood
Blood (2009) 114 (22): 4251.
https://doi.org/10.1182/blood.V114.22.4251.4251
Published: 2009
Journal Articles

High WT1 Expression Has An Independent Positive Influence On CR Rate and EFS in Non M3 AML Patients Treated with Chemotherapy.

Nicoletta Colombo, Raffaella Grasso, Maurizio Miglino, Marino Clavio, Gianmatteo Pica, MD, Germana Beltrami, Micaela Bergamaschi, Carlo Marani, Antonia Cagnetta, Anna Ghiso, Laura Mitscheunig, Ivana Pierri, Filippo Ballerini, Letizia Canepa, Sara Aquino, Enrico De Astis, Angelo Michele Carella, Marco Gobbi
Journal: Blood
Blood (2009) 114 (22): 4675.
https://doi.org/10.1182/blood.V114.22.4675.4675
Published: 2009
Journal Articles

Imatinib Achieves High Rates of Complete Citogenetic Remission (CCR) in CML Patients Relapsed after Autografting anf IFN-α Therapy.

Maria T. Corsetti, MD, Germana Beltrami, MD, A.M. Carella, MD
Journal: Blood
Blood (2004) 104 (11): 4656.
https://doi.org/10.1182/blood.V104.11.4656.4656
Published: 2004
Journal Articles

Peg-Filgrastim after Autologous Peripheral Blood Stem Cell Transplantation in Hematological Malignancies.

Pellegrino Musto, Potito Rosario Scalzulli, Lorella Melillo, Michele Nobile, Matteo Dell’Olio, Antonio La Sala, Saverio Mantuano, Carlo Bodenizza, Antonietta Falcone, Grazia Sanpaolo, Angelo Michele Carella, Michele Mario Greco, Germana Beltrami, Nicola Cascavilla
Journal: Blood
Blood (2004) 104 (11): 5200.
https://doi.org/10.1182/blood.V104.11.5200.5200
Published: 2004
Journal Articles

Reduced Intensity Conditioning Regimen for Allografting Following Cytoreductive Autografting in Metastatic Breast Cancer.

A.M. Carella, MD, Germana Beltrami, MD, Maria T. Corsetti, MD, Potito Scalzulli, MD, Michele Carella, MD, Roberta Gonella, MD, Alberto Ballestreo, MD, Franco Patrone, MD
Journal: Blood
Blood (2004) 104 (11): 5129.
https://doi.org/10.1182/blood.V104.11.5129.5129
Published: 2004